| Literature DB >> 33193756 |
Abstract
BACKGROUND: Large epidemiological studies on patterns of skin diseases in Saudi Arabia are scarce. Therefore, this systematic review and meta-analysis was conducted to gather available epidemiologic data describing the pattern of skin diseases in different geographical areas in Saudi Arabia.Entities:
Year: 2020 PMID: 33193756 PMCID: PMC7641721 DOI: 10.1155/2020/5281957
Source DB: PubMed Journal: Dermatol Res Pract ISSN: 1687-6113
Figure 1PRISMA flow diagram.
Baseline characteristics and summary of the included studies.
| Study ID | Region | Type of study | Sample size | Nationality | Time Period | Criteria of classification | Age (years) | Gender | Most common age | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Saudi | Expatriates | Male, | Female, | ||||||||
| Albasri et al. 2018 | Madinah | Retrospective hospital-based study (pathology based) | 202 | NR | Jan 2006 to Dec 2017 | NR | 60.1 ± 15 | 139 (68.8%) | 63 (31.2%) | 60–69 | |
| Albasri et al. 2019 | Madinah | Retrospective hospital-based study (pathology based) | 1125 | NR | Jan 2006 to Dec 2017 | ICD-10 | 36.9 ± 9.8 | 579 (51.5%) | 546 (48.5%) | 20–49 | |
| Alakloby 2005 | King Fahd Hospital, Al-Khobar, eastern province | Prospective hospital-based study | 1676 | 432 (85.5%) | 244 (14.6%) | Aug 2002 to Jul 2003 | ICD | NR | 820 (49%) | 856 (51%) | Adults 1,274 (76%) 13 years, and children 402 (24%) <13 years |
| Ahmed et al. 2016 | Qunfudah region | Retrospective hospital-based study | 792 | NR | Oct 2015 to Sep 2016 | NR | Mean age in females (29.2) and males (31.1) | 342 (43.2%) | 450 (56.8%) | 15–24 (25.1%) | |
| Alghanmi et al. 2013 | Jeddah | Retrospective hospital-based study (pathology based) | 360 | NR | Jan 2005 to Dec 2010 | NR | NR | F > M | F > M | >46 | |
| Al-Maghrabi et al. 2004 | Al-Baha, south western region | Retrospective hospital-based study (pathology based) | 193 | 189 (98%) | 4 (2%) | Jan 1990 to Jul 2003 | NR | Mean age 62.2 years | 119 (62%) | 74 (38%) | 60–80 |
| Al-Saeed et al. 2006 | Al-Khobar city, eastern province | Cross-sectional study | 2239 | 1844 (82.4%) | 395 (17.6%) | Jan to Mar 2003 | ICD-10 | 10.49 ± 2.64 | Female schoolchildren | 6–17 | |
| Al Shammrie et al. 2017 | Hail region | Retrospective hospital-based study | 13778 | 12,574 (92%) | 1204 (8%) | Jan 2008 to Dec 2014 with missing two years (2010–2011) | NR | NR | 5473 (40%) | 8305 (60%) | NR |
| Alshammari et al. 2018 | Hail region | Retrospective hospital-based study (histopathology based) | 458 | NR | NR | Jan 2014 to Apr 2017 | NR | 34.29 ± 17.5 | 242 (52.8%) | 216 (47.2%) | 30–39 |
| Alshamrani et al. 2019 | Jeddah, western region | Retrospective hospital-based study | 1244 | 809 (65%) | 435 (35%) | January 2017 to December 2017 | ICD-10 | 35 ± 3.8 | 365 (29.3%) | 879 (70.7% | Children 127 (10.2%) (<13 years), adults 982 (78.9%) (13–60 years), and elders 135 (10.9%) (>60 years) |
| Al Shobaili 2010 | Qassim region | Prospective hospital-based study | 3051 | 3051 (100%) | 0 | Mar 2008 to Feb 2009 | NR | 25.3 ± 14.9 | 1786 (58.5%) | 1265 (41.5%) | 5–34 |
| Bahamdan et al. 1995 | Abha, southern region, Saudi Arabia | Prospective hospital-based study | 1223 | 939 (76.8%) | 284 (23.2%) | Mar 1992 to Mar 1993 | ICD-9 | NR | 667 (54.54%) | 556 (45.46%) | Adults 848 (>13 years) and children 375 (30.7%) (<13 years). |
| Parthasaradhi et al. 1998 | Hail region, Saudi Arabia | Prospective hospital-based study | 3298 | 2772 (84.05%) | 526 (15.95%) | Jul 1995 to Jun 1997 | ICD-9 | NR | 1819 (55.16%) | 1479 (44.84%) | Adults 2535 (>13 years) and children 763 (<13 years) |
| Shelleh et al. 2004 | Najran | Retrospective hospital-based study (pathology based) | 1192 | 1003 (84.1%) | 189 (15.9%) | Dec 2000 to Dec 2001 | ICD-9 | NR | 562 (47.1%) | 630 (52.9%) | Children 302 (25.3%) and adults 890 |
Evaluation of the risk of bias in included primary studies.
| Study ID | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Overall risk of study bias |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Albasri et al. 2018 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Albasri et al. 2019 | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Alakloby 2005 | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Ahmed et al. 2016 | High risk | High risk | High risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Moderate risk |
| Alghanmi et al. 2013 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Al-Maghrabi et al. 2004 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Al-Saeed et al. 2006 | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
| Al Shammrie et al. 2017 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
| Alshammari et al. 2018 | High risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Alshamrani et al. 2019 | High risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
| Al Shobaili 2010 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Bahamdan et al. 1995 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Parthasaradhi et al. 1998 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Shelleh et al. 2004 | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
List of the 10 questions (Q1–Q10) applied to the studies: Q1. Was the study's target population a close representation of the national population in relation to relevant variables, e.g., age, sex, occupation? Q2. Was the sampling frame a true or close representation of the target population? Q3. Was some form of random selection used to select the sample, OR, was a census undertaken? Q4. Was the likelihood of nonresponse bias minimal? Q5. Were data collected directly from the subjects (as opposed to a proxy)? Q6. Was an acceptable case definition used in the study? Q7. Was the study instrument that measured the parameter of interest shown to have reliability and validity (if necessary)? Q8. Was the same mode of data collection used for all subjects? Q9. Was the length of the shortest prevalence period for the parameter of interest appropriate? Q10. Were the numerator(s) and denominator(s) for the parameter of interest appropriate?
Figure 2Forest plot of the pooled proportion for the prevalence of (a) pigmentary disorders, (b) dermatitis, (c) infectious diseases, (d) disorders of skin appendages, and (e) papulosquamous disorders.
Pooled proportion of the skin diseases pattern in Saudi Arabia.
| Skin diseases | Pooled proportion (%) | 95% CI | |
|---|---|---|---|
| Pigmentary Disorder | |||
| Melanocytic nevi | 54.2 | 52.2%–56.1% | |
| Postinflammatory hypo- and hyperpigmentation | 47 | 45%–49% | |
| Vitiligo | 6 | 5.6%–6.3% | |
| Melasma | 2.5 | 2.2%–3% | |
|
| |||
| Dermatitis/eczema and related conditions | |||
| Contact dermatitis | 4.7 | 4.3%–5.1% | |
| Seborrheic dermatitis | 2.3 | 2%–2.7% | |
| Atopic dermatitis | 1.2 | 1.1%–1.3% | |
| Pityriasis alba | 1.6 | 1.2%–2.1% | |
|
| |||
| Disorder of skin appendages | |||
| Acne | 1.8 | 1.7%–1.8% | |
| Alopecia | 7.5 | 7.1%–7.8% | |
|
| |||
| Infectious diseases | |||
| Cutaneous leishmaniasis | 4 | 3.7%–4.3% | |
| Scabies | 0.6 | 0.4%–0.8% | |
| Warts | 7.2 | 6.8%–7.5% | |
| Chicken pox | 6.9 | 6.2%–7.7% | |
| Herpes simplex | 1.2 | 0.9%–1.5% | |
| Herpes zoster | 1.8 | 1.5%–2.2% | |
| Bacterial | 3.3 | 3%–3.6% | |
| Onychomycosis | 2.8 | 2.3%–3.4% | |
| Tinea | 2.3 | 2.1%–2.5% | |
| Dermatophytosis | 6.6 | 5.8%–7.4% | |
| Candidiasis | 1.6 | 1.3%–2% | |
| Pityriasis versicolor | 1.2 | 0.8%–1.7% | |
|
| |||
| Papulosquamous disorders | |||
| Psoriasis | 3.9 | 3.6%–4.1% | |
| Lichen planus | 1.8 | 1.6%–2.1% | |
| Pityriasis rosea | 1.2 | 1%–1.5% | |
Comparison between males and females regarding the skin diseases pattern in Saudi Arabia.
| Skin diseases | Males | Total | Females | Total | Odds ratio (95% CI) |
|---|---|---|---|---|---|
| Pigmentary Disorder | |||||
| Melanocytic nevi | 48 | 944 | 92 | 1425 | 0.48 (0.33, 0.69) |
| Postinflammatory hypo and hyperpigmentation | 20 | 1185 | 41 | 1735 | 0.58 (0.33, 1.00) |
| Vitiligo | 149 | 3671 | 119 | 3770 | 1.20 (0.94, 1.55) |
| Melasma | 18 | 3218 | 86 | 2881 | 0.18 (0.11, 0.31) |
|
| |||||
| Dermatitis/eczema and related conditions | |||||
| Contact dermatitis | 222 | 4812 | 270 | 4946 | 0.82 (0.68, 0.98) |
| Seborrheic dermatitis | 93 | 4250 | 88 | 4316 | 1.13 (0.84, 1.52) |
| Atopic dermatitis | 501 | 4812 | 487 | 4946 | 1.11 (0.97, 1.27) |
|
| |||||
| Disorder of skin appendages | |||||
| Acne | 353 | 3566 | 636 | 3844 | 0.57 (0.49, 0.65) |
| Alopecia | 179 | 4145 | 378 | 4390 | 0.48 (0.40, 0.58) |
|
| |||||
| Infectious diseases | |||||
| Cutaneous leishmaniasis | 185 | 4250 | 78 | 4316 | 2.07 (1.58, 2.72) |
| Scabies | 25 | 3671 | 21 | 3770 | 1.19 (0.67, 2.12) |
| Warts | 356 | 4250 | 239 | 4316 | 1.49 (1.25, 1.77) |
| Chicken pox | 46 | 3306 | 25 | 2891 | 1.53 (0.94, 2.50) |
| Herpes simplex | 28 | 3671 | 21 | 3770 | 1.44 (0.80, 2.58) |
| Herpes zoster | 72 | 3430 | 62 | 3460 | 1.23 (0.86, 1.75) |
| Bacterial | 190 | 4549 | 118 | 4169 | 1.80 (1.41, 2.30) |
| Dermatophytosis | 192 | 3430 | 157 | 3460 | 1.53 (1.22, 1.91) |
| Candidiasis | 41 | 3671 | 53 | 3770 | 0.69 (0.46, 1.05) |
| Pityriasis versicolor | 49 | 1852 | 28 | 2291 | 2.22 (1.37, 3.58) |
|
| |||||
| Papulosquamous disorders | |||||
| Psoriasis | 163 | 4250 | 159 | 4316 | 1.11 (0.88, 1.39) |
| Lichen planus | 63 | 4250 | 84 | 4316 | 0.78 (0.56, 1.09) |
| Pityriasis rosea | 46 | 4250 | 55 | 4316 | 0.83 (0.56, 1.22) |
Figure 3Forest plot of the pooled proportion for the prevalence of skin cancer: (a) benign neoplasm and (b) malignant neoplasm.
Figure 4Pie chart summary of the pooled proportion for the prevalence malignant neoplasm.